We are a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer.
Click on the link below for our latest corporate presentation.
We are a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer.
Click on the link below for our latest corporate presentation.
We participate in many investor and scientific conferences throughout the year and routinely make available related webcasts and presentations.
Clink on the link below for details on past and future events.